1-16996954-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022089.4(ATP13A2):​c.1195+66A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.822 in 1,566,436 control chromosomes in the GnomAD database, including 530,914 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.81 ( 49717 hom., cov: 32)
Exomes 𝑓: 0.82 ( 481197 hom. )

Consequence

ATP13A2
NM_022089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.18

Publications

6 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, G2P, ClinGen
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 1-16996954-T-C is Benign according to our data. Variant chr1-16996954-T-C is described in ClinVar as Benign. ClinVar VariationId is 1192485.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.86 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP13A2NM_022089.4 linkc.1195+66A>G intron_variant Intron 12 of 28 ENST00000326735.13 NP_071372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP13A2ENST00000326735.13 linkc.1195+66A>G intron_variant Intron 12 of 28 1 NM_022089.4 ENSP00000327214.8 Q9NQ11-1

Frequencies

GnomAD3 genomes
AF:
0.807
AC:
122642
AN:
152014
Hom.:
49690
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.746
Gnomad AMI
AF:
0.798
Gnomad AMR
AF:
0.872
Gnomad ASJ
AF:
0.818
Gnomad EAS
AF:
0.846
Gnomad SAS
AF:
0.736
Gnomad FIN
AF:
0.845
Gnomad MID
AF:
0.807
Gnomad NFE
AF:
0.824
Gnomad OTH
AF:
0.821
GnomAD4 exome
AF:
0.824
AC:
1165591
AN:
1414304
Hom.:
481197
AF XY:
0.822
AC XY:
575821
AN XY:
700902
show subpopulations
African (AFR)
AF:
0.747
AC:
24223
AN:
32416
American (AMR)
AF:
0.884
AC:
33229
AN:
37590
Ashkenazi Jewish (ASJ)
AF:
0.813
AC:
20675
AN:
25438
East Asian (EAS)
AF:
0.841
AC:
31335
AN:
37244
South Asian (SAS)
AF:
0.749
AC:
61589
AN:
82272
European-Finnish (FIN)
AF:
0.841
AC:
41080
AN:
48862
Middle Eastern (MID)
AF:
0.818
AC:
3345
AN:
4088
European-Non Finnish (NFE)
AF:
0.829
AC:
902202
AN:
1087858
Other (OTH)
AF:
0.819
AC:
47913
AN:
58536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
11608
23216
34825
46433
58041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20666
41332
61998
82664
103330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.807
AC:
122716
AN:
152132
Hom.:
49717
Cov.:
32
AF XY:
0.807
AC XY:
60039
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.746
AC:
30954
AN:
41494
American (AMR)
AF:
0.873
AC:
13349
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.818
AC:
2837
AN:
3468
East Asian (EAS)
AF:
0.846
AC:
4348
AN:
5140
South Asian (SAS)
AF:
0.737
AC:
3550
AN:
4820
European-Finnish (FIN)
AF:
0.845
AC:
8967
AN:
10614
Middle Eastern (MID)
AF:
0.816
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
0.824
AC:
56029
AN:
67982
Other (OTH)
AF:
0.813
AC:
1716
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1243
2486
3730
4973
6216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
874
1748
2622
3496
4370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.770
Hom.:
3321
Bravo
AF:
0.808
Asia WGS
AF:
0.745
AC:
2590
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 93. Only high quality variants are reported. -

Autosomal recessive spastic paraplegia type 78 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kufor-Rakeb syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.84
DANN
Benign
0.53
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9435736; hg19: chr1-17323449; API